Cells Power Corporation was founded in 2014 in Tokyo, Japan with the vision to increase life expectancy and improve the quality of life through the development of regenerative medical technologies. To ensure these goals are achieved to the highest satisfaction, our corporation makes efforts to accumulate the most advanced bio-cultivation and medical technologies from around the world, create our own R&D and production laboratories, collaborate with international industry leaders, establish our own medical institutions, spread awareness of regenerative medicine and new bio-technologies through social and educational activities, and develop our innovative medical products. The name and mascot Kintaro was adopted in 2016 to be a recognizable “made in Japan” brand, also symbolizing the health and vitality associated with regenerative medicine. Our featured product is our patented "Kintaro Cells", a uniquely designed allogenic Bone Marrow Mesenchymal Stem Cell product. It is an achievement of international collaboration and over 50 years of research.
1989 Graduate from Novosibirsk State University with a Master’s Degree in Philosophy.
2002 Receive Master’s of Business Administration in Moscow
Alexei holds 28 years of international business experience, 22 of those years based in Japan Business included international medical tourism, net and software development, international trade, and the field of bio-technology sales and development. He established a stem cells research and production lab in Singapore in 2011 following his own treatment using BM-MSC, and in 2014 he founded Kintaro Cells Power Corporation in Tokyo, Japan.
1974 Born in Yamaguchi prefecture in Japan.
1997 Graduate from Keio University, Faculty of Law, Department of Politics
2007 Graduate from Peking University with Masters degree at the School of International Studies
Former work: Nippon Life Insurance Company, member of House of Representative, researcher at Graduate School of Media Design at Keio University.At the House of Representative, he belonged to the Committee of Economy, Trade and Industry and worked for developing law to expand regenerative medicine, expanding medical equipment export, developing industry for new energy, promoting technology collaboration between Japan and Taiwan and Asia trade, reconstruction of The Great East Japan Earthquake, and development of radiation protection and decontamination technology. In November 2015, he founded IM Hospital Corporation and become CEO of the company. He worked for development and diffusion of preventive medical care system aiming for the reduction of emergency transport in the remote locations. At the end 2015, he met Alexei and gave consultation for the expansion of the BM-MSC business. He introduced him to Ryukyu University, Tokyo Medical University and domestic researchers. In 2016, he became an executive director at Kintaro Cells Power Corporation.
1967 Born in Yamaguchi prefecture in Japan
He started working for Nippon Life Insurance Company and work for 10 years at the company. From 2001, he worked for franchising the vicarious service of private import and the complex type food restaurant industry. However, he decided to withdraw from it because of the downturn after the 2008 financial crisis. In 2008, he founded Turbulence and become CEO of the company. He specialized in exchange.Currently, he does selection of operational methods and FX broker and proposal of various structure, using his experience as professional trader.
He started working for Kintaro Cells Power from Summer 2016. He is responsible for the sales business control and struturing in funding.
2015 - Shin Nihon Medical Research Institute Co., Ltd. (Hong Kong) CEO of Medical Research
2016 ~ Deputy General Manager of Fujian Five Hertz Biology Technology Co., Ltd.
2017 ~ Deputy General Manager of Five Hertz (Xiamen) Medical Supplies Co., Ltd.
2017 ~ Kintaro Cells Power Excective director.
Yoji Kishi has been involved in medical business for more than 15 years. He graduated from Tohoku University Pharmaceutical College and obtained national qualification as a pharmacist. He joined Johnson & Johnson Group Company from 1999 to 2009, where he was in charge of marketing and public relations as a manager of large medical device sales and marketing communication for hospitals. Now, have charged to develop Kintaro Cells in hospital medicine industry worldwide.
2013 Graduate from Temple University with BA degree in film production and marketing promotion.
Mr. Wilkinson joined Kintaro Cells Power Corporation in January 2016, and currently works with all forms of media to promote the company. He uses online marketing, social media promotion, website construction, graphic design, translation, photography and video to further expand Kintaro Cells Power Co.'s client and partner base.
Toyama first succeeded with a business model that matches telephone cards and communication. Became representative director of LOHAS brand co., Ltd.
Developed business models that specialize in the orders of Chinese rich people and the desires of Chinese enterprises.
Established Chengdu LOHAS Brand Co., Ltd. in China. Started exporting various goods to the Chinese market. Later, he established the Japan-China Economic Investment Exchange Association at the request of Deloitte Tohmatsu. Both businesses in Japan and China will be promoted, and support for legal affairs, taxation and contract will be carried out.
A luxury Japanese style "beauty salon salon" opened in the Chinese market.
After encountering Alexei, and learning about the therapeutic effect of Kintaro Cells, Toyama became an officer of Kintaro Cells Power in Japan.
Together, Toyama and Kintaro Cells Power have opened a store of "medical beauty salon salon" for the Chinese market.